-
Cerulean Pharma Inc (NASDAQ: CERU) shares dipped
27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has
gained 15.31 percent in the same period.
-
Tandem Diabetes Care Inc (NASDAQ: TNDM) shares
tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
-
Alphatec Holdings Inc (NASDAQ: ATEC) shares fell
21.1 percent to $2.10 as the company reported a $18.9 million private placement.
-
Heat Biologics Inc (NASDAQ: HTBX) shares dropped
15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
-
Rave Restaurant Group Inc (NASDAQ: RAVE) shares
fell 15 percent to $1.76.
-
QuickLogic Corporation (NASDAQ: QUIK) shares
declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
-
Orion Engineered Carbons SA (NYSE: OEC) shares
dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
-
Interpace Diagnostics Group Inc (NASDAQ: IDXG)
shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and
milestone obligations.
-
Ultragenyx Pharmaceutical Inc (NASDAQ: RARE)
declined 7.4 percent to $72.56 after the company reported topline data from Phase 2 UXOO7 study. The trial did not meet primary
endpoint. PiperJaffray downgraded Ultragenyx Pharmaceutical from Overweight to Neutral.
-
Proofpoint Inc (NASDAQ: PFPT) shares declined 5.1
percent to $75.13. Goldman Sachs downgraded Proofpoint from Neutral to Sell.
-
Pulmatrix Inc (NASDAQ: PULM) shares fell 5.1
percent to $3.70 after rising 0.52 percent on Wednesday.
-
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM) fell
4.5 percent to $13.73. Bellicum Pharmaceuticals reported a proposed public offering of 5 million shares of common stock.
-
Cherry Hill Mortgage Investment Corp (NYSE: CHMI)
declined 4.2 percent to $17.60 as the company reported a 4.5 million share offering.
-
Merit Medical Systems, Inc. (NASDAQ: MMSI)
declined 4 percent to $28.42. Merit Medical priced 4.5 million share public offering of common stock at $28.25 per share.
-
Centene Corp (NYSE: CNC) shares fell 3.2 percent to
$65.86. Citi downgraded Centene from Buy to Neutral.
Latest Ratings for CERU
Date |
Firm |
Action |
From |
To |
Aug 2016 |
Barclays |
Maintains |
|
Overweight |
Aug 2016 |
Wedbush |
Downgrades |
Outperform |
Neutral |
Aug 2016 |
Leerink Swann |
Downgrades |
Outperform |
Market Perform |
View More Analyst Ratings for
CERU
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.